MitoGlow-ROS: İnme ve Nöroinflamasyonun Hücresel ve Hayvansal Modellerinde Mitokondriyal ROS'u İzlemek İçin Yeni Bir Floresan Probu

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

Mitochondrial reactive oxygen species (mtROS) play a critical role in neuroinflammatory and neurodegenerative disorders, necessitating precise tools for their detection. This study validates MitoGlow-ROS as a highly sensitive and specific probe for quantifying mitochondrial superoxide in cell-free systems, PC12 cells, Lipopolysaccharide (LPS)-treated primary neuronal cultures, and in vivo LPS-treated Sprague-Dawley rats. In cell-free systems, MitoGlow-ROS exhibited a 45-fold dynamic range (R² = 0.97) and a limit of detection of 0.05 µM/min, outperforming MitoSOX Red, with enhanced reproducibility and specificity via its dynamic quenching mechanism. In PC12 cells with antimycin A, it detected a dose-dependent 5-fold ROS increase, reduced by 80% with N-acetylcysteine, confirming mitochondrial superoxide specificity. In LPS-treated neuronal cultures, MitoGlow-ROS captured a 3.4-fold ROS peak at 6 hours, correlating with robust early upregulation of inflammatory mediators (e.g., IL6: 1726-fold) and antioxidant enzymes (e.g., SOD2: 8.6-fold) at 3 hours. In vivo, it revealed a 4.1-fold hippocampal and 2.8-fold cortical ROS increase, validated by corresponding mRNA changes. Despite limitations in acute modeling and functional outcome assessments, MitoGlow-ROS’s sensitivity to subtle and significant mtROS changes positions it as a powerful tool for studying oxidative stress in stroke, Alzheimer’s disease, Parkinson’s disease, and other neuroinflammatory disorders, supporting future investigations into disease mechanisms and therapeutic interventions

İlgili konular